Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck U.S. Chargebacks & Rebates Accrual by Year
U.S. Chargebacks & Rebates Accrual — Current-Year Sales Provision ($M) ($M)
Merck U.S. Chargebacks & Rebates Accrual: $10,219M in FY2025, down 24.0% from a year earlier.
Latest, FY2025
10,219
Period ended Dec 31, 2025
Change on a year earlier
-24.0%
13,450 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below
Where the FY2025 figure comes from
“|| Current provision | 10,219 | 13,450”
Source: Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
Reported in Form 10-K Critical Accounting Estimates.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Chargebacks & Rebates Accrual — Current-Year Sales Provision ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,219 | -24.0% | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 13,450 | +7.3% | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 12,540 | +1.1% | Form 10-K (mrk-20241231.htm, filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 12,408 | 0.0% | Form 10-K (mrk-20231231.htm, filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 12,412 | +8.7% | Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 11,423 | -4.8% | Form 10-K (mrk-20211231.htm, filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 11,999 | +10.7% | Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 10,837 | -1.5% | Form 10-K (mrk1231201910k.htm, filed 2020-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 11,001 | +11.9% | Form 10-K (mrk1231201810k.htm, filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 9,831 | – | Form 10-K (mrk1231201710k.htm, filed 2018-02-27) ↗ |
Cite this data
StockData. (2026). Merck U.S. Chargebacks & Rebates Accrual ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/gtn-us-roll-prov
See every metric in the Merck KPI table. Data updated Oct 26, 2026.